Skip to content
Coming Soon·Opens soon·Synced from source July 6, 2026

Exposomic Contributions to ADRD Pathology and Resilience

National Institutes of Health

Posted
Mar 11, 2026
Closes
No deadline published by the funder
Last verified
Jul 6, 2026

Classification and identifiers

Solicitation number
RFA-NS-26-031
Assistance listing (CFDA)
93.853

Amount

Amount not published by the funder

Who can apply

Tribal organizationsNonprofits (non-501c3)Public universitiesHousing authoritiesPrivate universitiesFor-profits

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

About this opportunity

The National Institute of Neurological Disorders and Stroke (NINDS) is interested in supporting research projects that investigate how specific neural exposome factors contribute mechanistically to Alzheimer’s disease-related dementias (ADRD) pathology and resilience. For the purposes of this program, exposome factors of interest include, but are not limited to, environmental toxins, sleep and circadian rhythms, stress, and the real-world conditions that modulate them (e.g., light, noise, heat). Applications will be expected to propose research on the synergistic action between multiple exposome factors, and the composite effects of mixtures of exposome factors on neural mechanisms relevant to ADRD. Applicants are encouraged to focus on mechanistic pathways (e.g., microbiome–brain interact...

Finding similar opportunities...